Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 29, Issue -, Pages 77-89Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2016.07.005
Keywords
-
Categories
Funding
- NIH [K99/R00CA158055, R01 CA200673]
- V Foundation for Cancer Research
- Holden Comprehensive Cancer Center, University of Iowa
- AI/NIAID [T32 AI007260]
- Breast Cancer Research Grant
Ask authors/readers for more resources
Obesity is a growing public health problem and affects 35% US adults. Obesity increases the risk of many cancer types and is associated with poor outcomes. Clinical management of cancer patients has been essentially the same between normal weight and obese individuals. Understanding causal mechanisms by which obesity drives cancer initiation and progression is essential for the development of novel precision therapy for obese cancer patients. One caveat is that various mechanisms have been proposed for different cancer types for their progression under obesity. Since obesity is known to have global impact on inflammation, here we will summarize recent literature and discuss the potential of inflammation being the common causal mechanism to promote cancer promotion across cancer types.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available